文献速递瓣膜外科

二尖瓣手术同期行Cox迷宫术治疗心房颤动的长期结局

Long-term outcome following concomitant mitral valve surgery and Cox maze procedure for atrial fibrillation.
PubMed 文献 · J Thorac Cardiovasc Surg · 2017-11-14

本研究纳入473例二尖瓣手术同期行全Cox迷宫术的患者,按心律学会指南在术后6、9、12、18、24个月及此后每年至7年采集心律、用药和临床事件数据。结果显示围术期卒中2例(0.4%),手术死亡率2.7%(n=13);1、5、7年恢复窦性心律(不论是否用抗心律失常药)分别为90%、80%、66%,停用抗心律失常药的窦性心律分别为83%、69%、55%;7年免于栓塞性卒中为96.6%(每100患者年0.4次卒中),多数患者已停用抗凝。作者认为同期Cox迷宫术未增加手术风险,长期心律成功率可接受、心房颤动负荷降低且卒中率极低,外科医生经验可能显著影响长期消融成功率。

要点

  • 二尖瓣手术同期行全Cox迷宫术,围术期卒中0.4%、手术死亡率2.7%。
  • 1、5、7年恢复窦性心律分别为90%、80%、66%,停用抗心律失常药时分别为83%、69%、55%。
  • 7年免于栓塞性卒中96.6%(每100患者年0.4次),多数患者已停用抗凝。

核心结论

  • 本研究提示,即使在复杂度较高的情况下,二尖瓣手术同期加做Cox迷宫术并未增加手术风险。
  • 长期随访中,Cox迷宫术显示出可接受的心律成功率、降低的心房颤动负荷以及极低的卒中率。
  • 外科医生的个人经验和培训可能显著影响心房颤动外科消融的长期成功。

研究设计与样本

  • 本研究样本为接受二尖瓣手术同期行Cox迷宫术的患者473例。
  • 按心律学会指南在术后6、9、12、18、24个月及此后每年至7年采集心律、用药状态和临床事件数据。
  • 平均年龄65岁,平均左心房大小5.3 cm,15%为阵发性心房颤动。

主要发现

  • 围术期卒中发生2例(0.4%),手术死亡率为2.7%(n=13)。
  • 不论是否使用抗心律失常药,1、5、7年恢复窦性心律分别为90%、80%、66%。
  • 停用抗心律失常药时,1、5、7年窦性心律分别为83%、69%、55%。
  • 7年免于栓塞性卒中为96.6%(每100患者年0.4次卒中),多数患者已停用抗凝药。
  • 7年内房性心律失常复发的较高几率与心房颤动持续时间较长相关(OR 1.07;P=.001),较低几率与仅使用冷冻热能相关(OR 0.64;P=.045)及外科医生经验更丰富相关(OR 0.98;P=.025)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Atrial fibrillation (AF) is associated with increased early and long-term morbidity/mortality following valve surgery. This study examined long-term influence of concomitant full Cox maze (CM) and mitral valve procedures on freedom from atrial arrhythmia and stroke. METHODS: This sample comprised patients who underwent CM with a mitral valve procedure (N = 473). Data on rhythm, medication status, and clinical events captured according to Heart Rhythm Society guidelines at 6, 9, 12, 18, and 24 months and yearly thereafter up to 7 years. RESULTS: Mean age was 65 years, mean left atrium size was 5.3 cm, and 15% had paroxysmal AF. Perioperative stroke occurred in 2 patients (0.4%) and operative mortality was 2.7% (n = 13). Return to sinus rhythm regardless of antiarrhythmic drugs at 1, 5, and 7 years was 90%, 80%, and 66%. Sinus rhythm off antiarrhythmic drugs at 1, 5, and 7 years was 83%, 69%, and 55%. Freedom from embolic stroke at 7 years was 96.6% (0.4 strokes per 100 patient-years) with a majority of patients off anticoagulation medication. Greater odds of atrial arrhythmia recurrence during 7 years was associated with longer AF duration (odds ratio [OR], 1.07; P = .001), whereas lower odds were associated with cryothermal energy only (OR, 0.64; P = .045) and greater surgeon experience (OR, 0.98; P = .025). CONCLUSIONS: This study suggests that the addition of CM to mitral valve procedures, even with a high degree of complexity, did not increase operative risk. In long-term follow-up, the CM procedure demonstrated acceptable rhythm success, reduced AF burden, and remarkably low stroke rate. Individual surgeon experience and training may notably influence long-term surgical ablation for AF success.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Ad N, Holmes SD, Massimiano PS, et al. Long-term outcome following concomitant mitral valve surgery and Cox maze procedure for atrial fibrillation. J Thorac Cardiovasc Surg. 2017. PMID: 29246544. doi:10.1016/j.jtcvs.2017.09.147

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。